Literature DB >> 16033814

The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins.

Sang-Hyun Kwak1, Sanchayita Mitra, Khalil Bdeir, Derek Strassheim, Jong Sung Park, Jael Yeol Kim, Steven Idell, Douglas Cines, Edward Abraham.   

Abstract

Urokinase plasminogen activator (uPA) is a serine protease that catalyzes the conversion of plasminogen to plasmin. In addition, uPA has been shown to have proinflammatory properties, particularly in potentiating lipopolysaccharide (LPS)-induced neutrophil responses. To explore the mechanisms by which uPA exerts these effects, we examined the ability of specific uPA domains to increase cytokine expression in murine and human neutrophils stimulated with LPS. Whereas the addition of intact uPA to neutrophils cultured with LPS increased mRNA and protein levels of interleukin-1beta, macrophage-inflammatory protein-2, and tumor necrosis factor alpha, deletion of the kringle domain (KD) from uPA resulted in loss of these potentiating effects. Addition of purified uPA KD to LPS-stimulated neutrophils increased cytokine expression to a degree comparable with that produced by single-chain uPA. Inclusion of the arginine-glycine-aspartic but not the arginine-glycine-glutamic peptide to neutrophil cultures blocked uPA kringle-induced potentiation of proinflammatory responses, demonstrating that interactions between the KD and integrins were involved. Antibodies to alpha(V) or beta(3) integrins or to the combination of alpha(V)beta(3) prevented uPA kringle-induced enhancement of expression of proinflammatory cytokines and also of adhesion of neutrophils to the uPA KD. These results demonstrate that the KD of uPA, through interaction with alpha(V)beta(3) integrins, potentiates neutrophil activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033814     DOI: 10.1189/jlb.0305158

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  14 in total

1.  Regulation of urokinase expression at the posttranscription level by lung epithelial cells.

Authors:  Shwetha K Shetty; Amarnath S Marudamuthu; Daniel Abernathy; Rashmi S Shetty; Praveenkumar Shetty; Jian Fu; Steven Idell; Yashodhar P Bhandary; Honglong Ji; Ming-Cheh Liu; Sreerama Shetty
Journal:  Biochemistry       Date:  2011-12-23       Impact factor: 3.162

2.  PAI-1-derived peptide EEIIMD prevents impairment of cerebrovasodilation by augmenting p38 MAPK upregulation after cerebral hypoxia/ischemia.

Authors:  William M Armstead; John Riley; J Willis Kiessling; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-30       Impact factor: 4.733

3.  Urokinase plasminogen activator regulates pulmonary arterial contractility and vascular permeability in mice.

Authors:  Taher Nassar; Serge Yarovoi; Rami Abu Fanne; Otailah Waked; Timothy C Allen; Steven Idell; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-26       Impact factor: 6.914

4.  Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.

Authors:  Victoria Stepanova; Padma-Sheela Jayaraman; Sergei V Zaitsev; Tatiana Lebedeva; Khalil Bdeir; Rachael Kershaw; Kelci R Holman; Yelena V Parfyonova; Ekaterina V Semina; Irina B Beloglazova; Vsevolod A Tkachuk; Douglas B Cines
Journal:  J Biol Chem       Date:  2016-05-04       Impact factor: 5.157

5.  Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils.

Authors:  Yanping Yang; Arnaud Friggeri; Sami Banerjee; Khalil Bdeir; Douglas B Cines; Gang Liu; Edward Abraham
Journal:  Am J Respir Crit Care Med       Date:  2010-07-23       Impact factor: 21.405

6.  Association between urokinase haplotypes and outcome from infection-associated acute lung injury.

Authors:  John Arcaroli; Jeff Sankoff; Nianjun Liu; David B Allison; James Maloney; Edward Abraham
Journal:  Intensive Care Med       Date:  2007-11-10       Impact factor: 17.440

7.  Inhibition of integrin alphavbeta3 prevents urokinase plasminogen activator-mediated impairment of cerebrovasodilation after cerebral hypoxia/ischemia.

Authors:  J Willis Kiessling; Douglas B Cines; Abd Al-Roof Higazi; William M Armstead
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-23       Impact factor: 4.733

8.  Urinary trypsin inhibitor attenuates lipopolysaccharide-induced neutrophil activation.

Authors:  Seong-Heon Lee; Hwi-Jin Kim; Hui-Jing Han; Mei Li; Sang-Hyun Kwak; Sanghee Park
Journal:  Korean J Anesthesiol       Date:  2012-12-14

9.  The receptor for urokinase regulates TLR2 mediated inflammatory responses in neutrophils.

Authors:  Gang Liu; Yanping Yang; Shanzhong Yang; Sami Banerjee; Andressa De Freitas; Arnaud Friggeri; Kasey I Davis; Edward Abraham
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

10.  Potential role of kringle-integrin interaction in plasmin and uPA actions (a hypothesis).

Authors:  Yoshikazu Takada
Journal:  J Biomed Biotechnol       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.